Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Marlton

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
Leukemia & Lymphoma|May 24, 2013
The many facets of WT1 in acute myeloid leukemia: clarity remains elusivePaula Marlton
Annals of Hematology|July 8, 2010
Treatment of acute promyelocytic leukaemia in the Jehovah's Witness populationColm Keane, Peter Mollee, Paula Marlton, et al.
Blood|November 23, 2006
Increased mortality with FLA compared with ADE chemotherapy in high-risk AMLSteven W Lane, Paula Marlton, Peter N Mollee
Internal Medicine Journal|October 12, 2019
Author replyJudith Trotman, Chan Y Cheah, Paula Marlton, et al.
Internal Medicine Journal|September 20, 2018
Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphomaJudith Trotman, Chan Y Cheah, Paula Marlton, et al.
Internal Medicine Journal|March 1, 2019
Front-line management of indolent non-Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphomaChan Y Cheah, Stephen Opat, Judith Trotman, et al.
Internal Medicine Journal|July 8, 2017
Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucilConstantine Tam, Bryone Kuss, Stephen Opat, et al.
Asia-Pacific Journal of Clinical Oncology|March 29, 2014
Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patientsKathryn Jackson, Glen Kennedy, Peter Mollee, et al.
Leukemia & Lymphoma|December 8, 2010
Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian populationKirk Morris, Helen Weston, Peter Mollee, et al.
Pathology|March 21, 2002
Identification of tumours with the CD43 only phenotype during the investigation of suspected lymphoma: a heterogeneous group not necessarily of T cell originGlen A Kennedy, Gavin Cull, Devinder Gill, et al.
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Leukemia & Lymphoma|May 24, 2013
The many facets of WT1 in acute myeloid leukemia: clarity remains elusivePaula Marlton
Annals of Hematology|July 8, 2010
Treatment of acute promyelocytic leukaemia in the Jehovah's Witness populationColm Keane, Peter Mollee, Paula Marlton, et al.
Blood|November 23, 2006
Increased mortality with FLA compared with ADE chemotherapy in high-risk AMLSteven W Lane, Paula Marlton, Peter N Mollee
Internal Medicine Journal|October 12, 2019
Author replyJudith Trotman, Chan Y Cheah, Paula Marlton, et al.
Internal Medicine Journal|September 20, 2018
Front-line management of non-Hodgkin lymphoma in Australia. Part 1: follicular lymphomaJudith Trotman, Chan Y Cheah, Paula Marlton, et al.
Internal Medicine Journal|March 1, 2019
Front-line management of indolent non-Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphomaChan Y Cheah, Stephen Opat, Judith Trotman, et al.
Internal Medicine Journal|July 8, 2017
Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucilConstantine Tam, Bryone Kuss, Stephen Opat, et al.
Asia-Pacific Journal of Clinical Oncology|March 29, 2014
Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patientsKathryn Jackson, Glen Kennedy, Peter Mollee, et al.
Leukemia & Lymphoma|December 8, 2010
Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian populationKirk Morris, Helen Weston, Peter Mollee, et al.
Pathology|March 21, 2002
Identification of tumours with the CD43 only phenotype during the investigation of suspected lymphoma: a heterogeneous group not necessarily of T cell originGlen A Kennedy, Gavin Cull, Devinder Gill, et al.
Pageof 9